Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: A meta-analysis

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 4, 2015, Pages 4769-4777

  Sun, Da Wei ^a   Zhang, Ying Yi ^b   Qi, Yue ^a   Liu, Gui Qi ^a   Chen, Yu Guo ^a   Ma, Jian ^a   Lv, Guo Yue ^a  

^a JILIN UNIVERSITY   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

HCC; MACC1; Meta analysis; Prognosis

Indexed keywords

ALPHA FETOPROTEIN; METASTASIS ASSOCIATED IN COLON CANCER 1 PROTEIN; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

CANCER PROGNOSIS; CANCER RECURRENCE; DISEASE FREE SURVIVAL; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; META ANALYSIS; METASTASIS; OVERALL SURVIVAL; PATHOLOGY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR DIFFERENTIATION; TUMOR INVASION; TUMOR VOLUME;

EID: 84931272694     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. [1] Tabrizian P, Roayaie S, Schwartz ME. Current management of hepatocellular carcinoma. World J Gastroenterol 2014; 20: 10223-10237.
2. [2] Bertino G, Demma S, Ardiri A, Proiti M, Gruttadauria S, Toro A, Malaguarnera G, Bertino N, Malaguarnera M, Malaguarnera M, Di Carlo I. Hepatocellular carcinoma: novel molecular targets in carcinogenesis for future therapies. Biomed Res Int 2014; 2014: 203693.
3. [3] Chung H, Ueda T, Kudo M. Changing trends in hepatitis C infection over the past 50 years in Japan. Intervirology 2010; 53: 39-43.
4. [4] Davila JA, Kramer JR, Duan Z, Richardson PA, Tyson GL, Sada YH, Kanwal F, El-Serag HB. Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors. Hepatology 2013; 57: 1858-1868.
5. [5] Zhou Y, Sui C, Li B, Yin Z, Tan Y, Yang J, Liu Z. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol 2010; 8: 55.
6. [6] Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I, Birchmeier W, Schlag PM. MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 2009; 15: 59-67.
7. [7] Trusolino L, Bertotti A, Comoglio PM. MET signaling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol 2010; 11: 834-848.
8. [8] Gherardi E, Birchmeier W, Birchmeier C, Vande Woude G. Targeting MET in cancer: rationale and progress. Nat Rev Cancer 2012; 12: 89-103.
9. [9] Meng F, Li H, Shi H, Yang Q, Zhang F, Yang Y, Kang L, Zhen T, Dai S, Dong Y, Han A. MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway. PLoS One 2013; 8: e60821.
10. [10] Zhen T, Dai S, Li H, Yang Y, Kang L, Shi H, Zhang F, Yang D, Cai S, He Y, Liang Y, Han A. MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway. Oncotarget 2014; 5: 3756-3769.
11. [11] Stein U. MACC1-a novel target for solid cancers. Expert Opin Ther Targets 2013; 17: 1039-1052.
12. [12] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
13. [13] Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
14. [14] Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
15. [15] Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li C, Zhang JL, Zheng X, Yao YM. MACC1 expression correlates with PFKFB2 and survival in hepato­cellular carcinoma. Asian Pac J Cancer Prev 2014; 15: 999-1003.
16. [16] Qiu J, Huang P, Liu Q, Hong J, Li B, Lu C, Wang L, Wang J, Yuan Y. Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 2011; 9: 166.
17. [17] Yang YP, Qu JH, Chang XJ, Lu YY, Bai WL, Dong Z, Wang H, An LJ, Xu ZX, Wang CP, Zeng Z, Hu KQ. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med 2013; 11: 41.
18. [18] Qu JH, Chang XJ, Lu YY, Bai WL, Chen Y, Zhou L, Zeng Z, Wang CP, An LJ, Hao LY, Xu GL, Gao XD, Lou M, Lv JY, Yang YP. Overexpression of metastasis-associated in colon cancer 1 predicts a poor outcome of hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2012; 18: 2995-3003.
19. [19] Xie C, Wu J, Yun J, Lai J, Yuan Y, Gao Z, Li M, Li J, Song L. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. PLoS One 2013; 8: e64235.
20. [20] Gao S, Lin BY, Yang Z, Zheng ZY, Liu ZK, Wu LM, Xie HY, Zhou L, Zheng SS. Role of overexpres sion of MACC1 and/or FAK in predicting prognosis of hepatocellular carcinoma after liver transplantation. Int J Med Sci 2014; 11: 268-275.
21. [21] Ding FH, Gao S, Han SS, Wang XL, Liu QG, Yao YM. Expression of MACC1 Protein in Hepatocellular Carcinoma and Its Relationship with the Prognosis of Patients. Acta Med Univ Sci Technol Huazhong 2013; 42: 464-468.
22. [22] Zhang YP, Li ZY, Wei HJ, Tang CF, Chang XW, Wang C. Expression of MACCl and C-MET proteins in hepatocellular carcinoma and its clinical relevance. Chin J Gen Surg 2013; 28: 534-537.
23. [23] Liu QQ, Liu QG, Zan XF, Guo C, Song T, Yao YM. Expression and clinical implications of MACC1 gene in hepatocellular carcinoma. Acta Med Univ Sci Technol Huazhong 2010; 39: 22-28.
24. [24] Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin 2012; 62: 394-399.
25. [25] Gao J, Ding F, Liu Q, Yao Y. Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem 2012; 376: 21-32.